Biotech Company, CEO Named In SEC Suit Over Alleged COVID-19 Blood Test Device
NEW YORK — The Securities and Exchange Commission sued a biotechnology company and its CEO in New York federal court on Dec. 17, alleging that the defendants violated federal securities laws...To view the full article, register now.
Already a subscriber? Click here to view full article